Company profile: Adient Medical
1.1 - Company Overview
Company description
- Provider of absorbable medical devices to prevent pulmonary embolism, including an Absorbable Vascular Filter that captures blood clots in the inferior vena cava for 12 weeks before dissolving into carbon dioxide and water.
Products and services
- Absorbable Vascular Filter: Bioabsorbable implant engineered to intercept thrombi in the inferior vena cava for 12 weeks, then resorbing into carbon dioxide and water to mitigate pulmonary embolism risk.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Adient Medical
Nellix
HQ: United States
Website
- Description: Provider of medical devices for minimally invasive treatment of aortic aneurysms, including abdominal (AAA) and thoracic (TAA), featuring an original device with a low-profile delivery system and innovative endograft designed to expand indications for less invasive care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nellix company profile →
Enchannel
HQ: China
Website
- Description: Provider of one-stop atrial fibrillation treatment solutions, offering the NanoAblate pulsed field ablation generator for non-thermal cardiac ablation; PFLine and PFBasket ablation catheters for flexible lesion sets and pulmonary vein isolation; and the DePolar 4D cardiac mapping system with DipperStar and LibStar catheters for real-time, high-resolution mapping.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enchannel company profile →
Acesion Pharma
HQ: Denmark
Website
- Description: Provider of medical drugs for the treatment of atrial fibrillation, developing therapies that inhibit a heart cell ion channel. Offerings include AP30663, an intravenous drug for acute cardioversion to sinus rhythm with demonstrated efficacy in clinical trials, and AP31969, an oral drug for maintenance of sinus rhythm in patients with atrial fibrillation, currently in clinical development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acesion Pharma company profile →
Aegerion Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapeutics to treat cardiovascular and metabolic diseases, focused on the development and commercialization of therapies, including lomitapide (AEGR-733), a microsomal triglyceride transfer protein inhibitor small molecule drug designed to decrease serum lipids.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aegerion Pharmaceuticals company profile →
CardiAQ Valve Technologies
HQ: United States
Website
- Description: Provider of innovative heart valve replacement solutions, initially focused on transcatheter mitral valve implantation (TMVI), a minimally invasive catheter-based procedure for replacing the heart's mitral valve.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardiAQ Valve Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Adient Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Adient Medical
2.2 - Growth funds investing in similar companies to Adient Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Adient Medical
4.2 - Public trading comparable groups for Adient Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →